Cardiovascular agents.
Grady Health System, Department of Pharmacy and Drug Information, Atlanta, Georgia 30303, USA. twalton@gmh.edu
Ted
T
Walton
Rebekah
R
Thomas
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy*; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D054796:Drug Dosage Calculations; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008508:Medication Errors / Q000517:prevention & control*; D006435:Renal Dialysis
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D002317:Cardiovascular Agents; D004077:Digoxin